| Literature DB >> 26709781 |
Liping Ma1, Namasivayam Ambalavanan2, Hui Liu3, Yong Sun4, Nirag Jhala4, Wayne E Bradley3, Louis J Dell'Italia5, Sue Michalek6, Hui Wu7, Chad Steele3, Raymond L Benza3, Yabing Chen8.
Abstract
Pulmonary arterial hypertension (PAH) contributes to morbidity and mortality of patients with lung and heart diseases. We demonstrated that hypoxia induced PAH and increased pulmonary arterial wall thickness in wild-type mice. Mice deficient in toll-like receptor 4 (TLR4-/-) spontaneously developed PAH, which was not further enhanced by hypoxia. Echocardiography determined right ventricular hypertrophy and decreased pulmonary arterial acceleration time were associated with the development of PAH in TLR4(-/-) mice. In pulmonary arterial smooth muscle cells (PASMC), hypoxia decreased TLR4 expression and induced reactive oxygen species (ROS) and Nox1/Nox4. Inhibition of NADPH oxidase decreased hypoxia-induced proliferation of wild-type PASMC. PASMC derived from TLR4(-/-) mice exhibited increased ROS and Nox4/Nox1 expression. Our studies demonstrate an important role of TLR4 in maintaining normal pulmonary vasculature and in hypoxia-induced PAH. Inhibition of TLR4, by genetic ablation or hypoxia, increases the expression of Nox1/Nox4 and induces PASMC proliferation and vascular remodeling. These results support a novel function of TLR4 in regulating the development of PAH and reveal a new regulatory axis contributing to TLR4 deficiency-induced vascular hypertrophy and remodeling.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26709781 PMCID: PMC4706231 DOI: 10.2741/4396
Source DB: PubMed Journal: Front Biosci (Landmark Ed) ISSN: 2768-6698